A case of complete recovery in a hypereosinophilic dermatitis patient with dupilumab

BACKGROUND: Hypereosinophilic dermatitis (HED) is a subtype of hypereosinophilic syndrome (HES). Glucocorticoids are preferred for treatment but carry substantial side effect profiles. Symptoms of HED may recur after systemic glucocorticoid tapering. As an interleukin-4 receptor (IL-4Rα) monoclonal...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xiaoyun, Ye, Jun, Wu, Xia, Zhu, Jiang, Chen, Siji, Cheng, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010203/
https://www.ncbi.nlm.nih.gov/pubmed/36912915
http://dx.doi.org/10.1007/s00011-023-01715-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010203/
https://www.ncbi.nlm.nih.gov/pubmed/36912915
http://dx.doi.org/10.1007/s00011-023-01715-1

Ejemplares similares